Upgrade to SI Premium - Free Trial

FDA approves MannKind autoinjector for heart failure edema

July 24, 2026 6:30 AM
MannKind Corporation (Nasdaq: MNKD) announced that the U.S. Food and Drug Administration has approved Furoscix ReadyFlow (furosemide injection), an autoinjector ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA